Cargando…
Medication-Related Osteonecrosis of the Jaws Bisphosphonates, Denosumab, and New Agents /
Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2015.
|
| Edición: | 1st ed. 2015. |
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Pharmacology of Antiresorptive Drugs
- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis
- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases
- Clinical Features, Localization, Definition and Staging of the Disease
- Radiological Findings / Imaging
- General Characteristics and Risk Factors for BRONJ
- Epidemiology
- Histopathology of BRONJ
- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs
- Bisphosphonates and Dental Implants
- Treatment of BRONJ
- Local and Microvascular Flaps in ONJ-Treatment
- Rehabilitation of Patients After BRONJ
- Adjuvant Treatment Strategies
- Microbiology and Antibiotics
- Animal Models of ONJ
- ONJ Under Denosumab and Other New Drugs
- Possible Use of Antiresorptive Drugs in OMS
- Dental Treatment Under BPs and After BRONJ
- Dental Rehabilitation Under Bisphosphonates and After BRONJ
- History of ONJ.